To test if the prognostic effects of ILEI, uPAR and an ILEI-uPAR combined analysis were applicable to all breast cancers, ILEI and uPAR scores were correlated with the metastasis-free survival of patients divided into the four major breast cancer subtypes. The gene discussed is PLAUR; the disease is breast cancer.